Bummer--Barrons | MRNA Message Board Posts


MRNA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  17651 of 17776  at  12/1/2021 12:05:00 PM  by

dar200


 In response to msg 17650 by  dar200
view thread

Re: Bummer--Barrons

 

Moderna Stock Tanks After Losing a Patent Dispute. Here's What Comes Next. -- Barrons.com

BY Dow Jones & Company, Inc.
— 11:58 AM ET 12/01/2021

Ben Levisohn

Moderna ( MRNA ) stock just keeps finding new reasons to drop.

Shares of Moderna ( MRNA) have tumbled 10% to $316.80 after a U.S. Court of Appeals for the Federal Circuit panel of three judges upheld a ruling against the biotech company in a decision on patents that Arbutus Biopharma ( ABUS ) says it owns. the patents in question regard lipid nanoparticles, which are used to deliver mRNA to cells safely.

The decision shouldn't have been much of a surprise, according to Dennis Ding, who notes that "it's rare for an appeal to reach oral arguments and reverse a prior IPR decision."

The news, while bad for Moderna ( MRNA), has been very good for Arbutus and Roivant Sciences ( ROIV) , which owns Arbutus stock. Shares of Arbutus have gained 69%, while Roivant is up 13%.

Still, it's unclear exactly what happens next. Ding notes that Arbutus could sue Moderna ( MRNA ) over the use of its patents in the Covid-19 vaccine, but that's something that takes a lot of time and it's still unclear how a full trial would turn out. The most likely outcome? "Ultimately, we think the parties will go to court but will settle for a small royalty in due course," writes Ding, who puts a potential royalty at about 5%.

Moderna ( MRNA) stock has dropped 18% over the past three months amid concerns about Pfizer's dominance of the Covid vaccine market and a separate patent battle with the U.S. government.

Write to Ben Levisohn at ben.levisohn@barrons.com

  (END) Dow Jones Newswires   12-01-21 1158ET   Copyright (c) 2021 Dow Jones & Company, 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...